ArticleTobacco prevention & cessation2023
Smoking cessation after myocardial infarction: Findings from a cross-sectional survey in Armenia.
Article in Tobacco prevention & cessation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07230249 (Effect of a Behavioral Intervention Delivered Via Telegram Messenger on Smoking Cessation in Patients After Myocardial Infarction), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Effect of a Behavioral Intervention Delivered Via Telegram Messenger on Smoking Cessation in Patients After Myocardial Infarction: The TELEGRAM-MI Randomized Controlled Trial
Who cites it
1 citing paper in PubMed, 1 citations in OpenAlex.
- Exploring social and environmental factors contributing to smoking initiation among Thai adolescents using advanced feature selection techniques.Tobacco prevention & cessation · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe effectiveness of smoking cessation in preventing myocardial infarction (MI) and reducing its recurrence, morbidity and mortality is well established. Only half of the patients quit or reduce smoking after hospitalization. The study examined smoking cessation practices and factors associated with it at 6-12 months after hospitalization among smoker patients diagnosed with MI.
methodsA cross-sectional survey (2016-2017) was conducted among smoker adult patients who were diagnosed with MI and were hospitalized at the largest cardiac hospital (Nork-Marash Medical Center) in Armenia. Data collection was conducted via medical record review and an interviewer-administered telephone survey (n=230). The patients were classified as non-quitters or quitters (those had not smoked even a puff within the past 30 days). Multivariate logistic regression analysis was used to examine factors associated with smoking cessation at 6-12 months post-hospitalization addressing multicollinearity with two separate regression models.
resultsThe mean age of participants was 58.3 years and 98.3% were males. Though almost all MI patients attempted to quit, only 52.2% were successful abstainers at 6-12 months after hospitalization. Significant predictors of quitting included higher self-efficacy (AOR=1.07; 95% CI: 1.03-1.11, p<0.001), lower tobacco dependence (AOR=0.81; 95% CI: 0.66-1.00, p=0.050), not having family members who smoked (Model 1: AOR=0.24; 95% CI: 0.08-0.70, p=0.009; and Model 2: AOR=0.24; 95% CI: 0.09-0.67, p=0.006), having other hospitalization after MI due to heart disease (Model 1: AOR=5.42; 95% CI: 1.50-19.65, p=0.010; and Model 2: AOR=4.20; 95% CI: 1.32-13.31, p=0.015), higher number of household members (Model 1: AOR=1.83; 95% CI: 1.27-2.64, p=0.001; and Model 2: AOR=1.68; 95% CI: 1.20-2.35, p=0.002), and having at least one comorbidity (Model 1: AOR=4.20; 95% CI: 1.47-12.04, p=0.008; and Model 2: AOR=3.74; 95% CI: 1.40-9.97; p=0.008).
conclusionsThe study emphasized the need for integrating evidence-based cessation services and targeted help for hospitalized MI patients in Armenia. Interventions should aim to improve self-efficacy, effectively treat dependence, and consider patients' social environment while providing cessation assistance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.